Glenn Jeffrey S 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Sep 5, 2017
Insider Transaction Report
Form 4
Glenn Jeffrey S
Director
Transactions
- Purchase
Common Stock
2017-09-01$9.53/sh+15,000$142,950→ 31,355 total
Holdings
- 460(indirect: By son)
Common Stock
- 151,064(indirect: See footnote)
Common Stock
Footnotes (1)
- [F1]Shares are held by Eiger Group International, Inc. ("EGI"). The Reporting Person is the Chief Executive Officer of EGI and has sole power to vote and sole power to dispose of shares directly owned by EGI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.